<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is a prothrombotic condition characterized by recurrent vascular <z:mp ids='MP_0005048'>thrombosis</z:mp> and/or pregnancy morbidity in the presence of circulating <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) involvement is a prominent feature of APS, and many neurological manifestations have been described in published reports </plain></SENT>
<SENT sid="2" pm="."><plain>There are limited data on psychiatric syndromes occurring in association with APS, and there have been no previous reports of <z:hpo ids='HP_0100754'>mania</z:hpo> associated with APS </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: The authors present the case of a 31-year-old man who experienced an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0349208" disease_type="Mental or Behavioral Dysfunction" abbrv="">manic episode</z:e> in association with APS </plain></SENT>
<SENT sid="4" pm="."><plain>They review the literature on psychiatric manifestations of APS, discuss potential mechanisms of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> pathogenesis, and consider diagnostic and treatment implications of the co-occurrence of APS and <z:e sem="disease" ids="C0852553" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychiatric symptoms</z:e> </plain></SENT>
</text></document>